Roche Venclexta/Venclyxto combination shows promising results in phase III VIALE-A study in Leukemia patients Medical Dialogues Bureau29 March 2020 12:15 PM ISTVenclexta/Venclyxto is being developed by AbbVie and Roche.
Roche Tecentriq, Avastin combo to increase overall survival, progression-free survival in HCC Medical Dialogues Bureau22 Oct 2019 9:50 AM ISTRoche, in its recent release, in 2018, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation (BTD) for Tecentriq in...
Roche names Eli Lilly executive Levi Garraway as chief medical officer Medical Dialogues Bureau20 Aug 2019 9:00 AM ISTLevi Garraway, most recently Eli Lilly's senior vice president, oncology research and development and Lilly research laboratories novel target...